JMA Calls for Early Avigan Use in High-Risk Patients Hospitalized with COVID-19

Yoshitake Yokokura, president of the Japan Medical Association (JMA), on April 28 called for giving Fujifilm’s antiviral Avigan (favipiravir) to high-risk patients with the novel coronavirus disease (COVID-19) early on in their hospitalization. At a press conference, Dr Yokokura revealed...read more